“Distribution of SALT Scores With Ritlecitinib Treatment up to 24 Months from the ALLEGRO Phase 2b 3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 6, Nov. 2024, p. s465, https://doi.org/10.25251/skin.8.supp.465.